Jemperli Evrópusambandið - íslenska - EMA (European Medicines Agency)

jemperli

glaxosmithkline (ireland) limited - dostarlimab - endometrial neoplasms - antineoplastic agents and antibody drug conjugates - jemparli is indicated as monotherapy for the treatment of adult patients with mismatch repair deficient (dmmr)/microsatellite instability-high (msi h) recurrent or advanced endometrial cancer (ec) that has progressed on or following prior treatment with a platinum-containing regimen.

Eusaprim Mixtúra, dreifa 8 mg/ml+40 mg/ml Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

eusaprim mixtúra, dreifa 8 mg/ml+40 mg/ml

aspen pharma trading limited - sulfamethoxazolum inn; trimethoprimum inn - mixtúra, dreifa - 8 mg/ml+40 mg/ml

Marcain spinal tung Stungulyf, lausn 5 mg/ml Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

marcain spinal tung stungulyf, lausn 5 mg/ml

aspen pharma trading limited - bupivacainum hýdróklóríð - stungulyf, lausn - 5 mg/ml

Ovestin Leggangakrem 1 mg/g Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

ovestin leggangakrem 1 mg/g

aspen pharma trading limited - estriolum inn - leggangakrem - 1 mg/g

Xylocain Hlaup 20 mg/g Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

xylocain hlaup 20 mg/g

aspen pharma trading limited - lidocainum hýdróklóríð - hlaup - 20 mg/g

Xylocain Húðúði, lausn 100 mg/ml Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

xylocain húðúði, lausn 100 mg/ml

aspen pharma trading limited - lidocainum inn - húðúði, lausn - 100 mg/ml

Xylocain adrenalin Stungulyf, lausn 10 mg/ml+5 míkróg/ml Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

xylocain adrenalin stungulyf, lausn 10 mg/ml+5 míkróg/ml

aspen pharma trading limited - lidocainum hýdróklóríð; adrenalinum bítartrat (epinephrinum bítartrat) - stungulyf, lausn - 10 mg/ml+5 míkróg/ml

Alofisel Evrópusambandið - íslenska - EMA (European Medicines Agency)

alofisel

takeda pharma a/s - darvadstrocel - endaþarm notast - Ónæmisbælandi lyf - alofisel er ætlað fyrir meðferð flókið endaþarminum fistulas í fullorðinn sjúklinga með ekki-virk/dálítið virk luminal crohn-sjúkdóm, þegar fistulas hafa sýnt ófullnægjandi svar að minnsta kosti einn hefðbundnum eða líffræðileg meðferð. alofisel ætti að nota eftir ástand notast.

Blenrep Evrópusambandið - íslenska - EMA (European Medicines Agency)

blenrep

glaxosmithkline (ireland) limited - belantamab mafodotin - mergæxli - Æxlishemjandi lyf - blenrep is indicated as monotherapy for the treatment of multiple myeloma in adult patients, who have received at least four prior therapies and whose disease is refractory to at least one proteasome inhibitor, one immunomodulatory agent, and an anti-cd38 monoclonal antibody, and who have demonstrated disease progression on the last therapy.